A detailed history of Cra Financial Services, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cra Financial Services, LLC holds 2,742 shares of NVO stock, worth $273,679. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,742
Previous 2,626 4.42%
Holding current value
$273,679
Previous $374,000 12.83%
% of portfolio
0.06%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$119.07 - $145.42 $13,812 - $16,868
116 Added 4.42%
2,742 $326,000
Q2 2024

Jul 11, 2024

BUY
$122.71 - $146.91 $7,976 - $9,549
65 Added 2.54%
2,626 $374,000
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $7,658 - $10,193
75 Added 3.02%
2,561 $328,000
Q3 2023

Oct 13, 2023

BUY
$90.94 - $199.54 $110,764 - $243,039
1,218 Added 96.06%
2,486 $226,000
Q1 2023

Apr 06, 2023

BUY
$132.34 - $159.14 $167,807 - $201,789
1,268 New
1,268 $201,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $225B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cra Financial Services, LLC Portfolio

Follow Cra Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cra Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cra Financial Services, LLC with notifications on news.